Apr 1, 2026, 17:15
Chokri Ben Lamine: Differentiating Reactive from Clonal Causes in Adult Neutrophilia
Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital and Research Center, shared a post on X:
“Neutrophilia approach: ANC greater than 7.5 ×10⁹/L (adult) should be classified reactive vs clonal
Step 1: confirm
- repeat CBC with differential
- review smear (toxic granulation? left shift? blasts?)
Step 2: severity and pattern
- mild (<15) | moderate (15–30) | severe (>30) | extreme (>50 = leukemoid?)
- acute vs chronic
Reactive causes (most common)
- infection (bacterial, severe viral early)
- inflammation (RA, IBD, vasculitis)
- stress (trauma, surgery, MI)
- drugs (steroids, G-CSF, lithium)
- smoking, obesity
- asplenia/post-splenectomy
Clonal / hematologic
- MPN: CML, PV, ET, MF
- CNL (rare, CSF3R+)
- AML with leukocytosis
- MDS/MPN overlap
Smear clues
- toxic granulation/Döhle bodies indicates a reactive
- basophilia with myelocyte bulge then think CML
- blasts raise concern for acute leukemia
Step 3: basic workup
- CRP/ESR
- cultures ± imaging if infection suspected
- medication review
Step 4: rule out CML early
BCR-ABL1 PCR (must not miss)
If persistent/unexplained
- JAK2 / CALR / MPL
- CSF3R if CNL suspected
- bone marrow biopsy
Red flags (urgent)
- WBC greater than 50–100
- blasts on smear
- organomegaly
- constitutional symptoms
Pearls
- neutrophilia with basophilia should be considered CML until proven otherwise
- steroid-induced neutrophilia results from demargination (no left shift)
- leukemoid reaction can mimic leukemia but LAP high
One-liner
most neutrophilia is reactive, but always exclude CML first”
Stay updated with Hemostasis Today.
-
Nov 21, 2026, 02:40Aniqa Gohar: One Heart Conclave – Advancing Integrated Thrombosis Care
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India